Name: UMIN ID:
Unique ID issued by UMIN | UMIN000014347 |
---|---|
Receipt number | R000016599 |
Scientific Title | Mycophenolate mofetil for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial(JSKDC07) |
Date of disclosure of the study information | 2014/06/23 |
Last modified on | 2021/12/28 11:43:28 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/06/23 11:41:47 | ||
2 | Update | 2015/06/23 11:38:13 | Recruitment status Anticipated trial start date |
|
3 | Update | 2015/06/23 11:39:19 | Key exclusion criteria |
|
4 | Update | 2016/08/19 09:32:09 | Key exclusion criteria Key exclusion criteria |
|
5 | Update | 2016/08/19 09:35:37 | Name of primary person or sponsor Organization Organization Organization Category of Funding Organization |
|
6 | Update | 2016/12/02 11:35:46 | Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
7 | Update | 2016/12/02 11:37:38 | Acronym |
|
8 | Update | 2016/12/02 11:40:27 | Key secondary outcomes |
|
9 | Update | 2018/08/16 11:12:47 | Recruitment status |
|
10 | Update | 2019/05/09 12:17:00 | Date of IRB Last follow-up date |
|
11 | Update | 2019/05/09 13:48:08 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Post marketing survey by drug manufacture etc., specified by Japanese law. Organization1 Tel1 Email1 Organization Organization Address Address Tel |
|
12 | Update | 2019/12/27 09:22:13 | Last follow-up date Date trial data considered complete Date analysis concluded |
|
13 | Update | 2021/12/28 11:43:28 | Recruitment status |